The Company Bringing Advertising to the Cord-Cutting Generation
It's a new age for advertising. Premion president Jim Wilson joined us at the New York Stock Exchange to discuss how the unit of station-owner TEGNA is capitalizing on the shift to OTT.
Premion says it offers advertisers better control of their ads than traditional tech. "We can literally hand over to our advertisers and let them know exactly where their ads ran," says Wilson, adding that his company is incredibly transparent. The focus for Premion, he says, is brand safety, a big issue nowadays for advertisers.
Wilson also views social media platforms such as Facebook and Twitter as contributing to the fragmentation of the OTT market. Premion incorporates these new competitors into its strategy, as the OTT advertising company continues to scale.
Finally, one of the areas Wilson says Premion is building out is its data management platforms. This is a product Wilson views as comparable to the ones created by Facebook, Google, and other large ad platforms. The company continues to focus on targeting as it builds out its audiences.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
